BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 7699469)

  • 1. The bisphosphonate dilemma.
    Koyano H; Schimizu T; Shishiba Y
    J Nucl Med; 1995 Apr; 36(4):705-6. PubMed ID: 7699469
    [No Abstract]   [Full Text] [Related]  

  • 2. Intravenous aminohydroxypropylidene bisphosphonate does not modify 99mTc-hydroxymethylene bisphosphonate bone scintigraphy. A prospective study.
    Macro M; Bouvard G; Le Gangneux E; Colin T; Loyau G
    Rev Rhum Engl Ed; 1995 Feb; 62(2):99-104. PubMed ID: 7600079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of clodronate treatment on bone scintigraphy in metastatic breast cancer.
    Pecherstorfer M; Schilling T; Janisch S; Woloszczuk W; Baumgartner G; Ziegler R; Ogris E
    J Nucl Med; 1993 Jul; 34(7):1039-44. PubMed ID: 8315476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A new bone scanning agent: clinical experience of 99mTc-hydroxymethane diphosphonate (HMDP) (author's transl)].
    Fukunaga M; Fujita T; Shigeno C; Morita R; Torizuka K
    Kaku Igaku; 1981 Jul; 18(6):863-7. PubMed ID: 7311135
    [No Abstract]   [Full Text] [Related]  

  • 5. Bisphosphonate treatment of bone metastases and hypercalcemia of malignancy.
    Coleman RE
    Oncology (Williston Park); 1991 Aug; 5(8):55-60; discussion 60-2, 65. PubMed ID: 1834153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bone scintigraphy in patients with malignancy associated with hypercalcemia].
    Fukunaga M; Otsuka N; Sone T; Nagai K; Ono S; Muranaka A; Furukawa T; Yanagimoto S; Tomomitsu T; Morita R
    Kaku Igaku; 1986 May; 23(5):495-8. PubMed ID: 3735789
    [No Abstract]   [Full Text] [Related]  

  • 7. Pitfalls of absent or faint kidney sign or bone scan.
    Constable AR; Cranage RW
    J Nucl Med; 1981 Jul; 22(7):658. PubMed ID: 6454765
    [No Abstract]   [Full Text] [Related]  

  • 8. [Four cases of diffuse bone metastasis with increased uptake in 99mTc-MDP bone scintigraphy].
    Dannoura R; Morita S; Kikuchi S; Ohta M; Ohtake H
    Kaku Igaku; 1984 Nov; 21(11):1521-5. PubMed ID: 6241644
    [No Abstract]   [Full Text] [Related]  

  • 9. [Significance of bone scintigraphy in the observation of the therapeutic effects in metastatic bone cancer].
    Kosuda S; Kondo M; Masaki H; Endo M; Ando Y; Takagi Y; Kubo A; Hashimoto S
    Nihon Igaku Hoshasen Gakkai Zasshi; 1982 May; 42(5):454-66. PubMed ID: 6217442
    [No Abstract]   [Full Text] [Related]  

  • 10. [Radiological diagnosis of bone metastasis of hepatoma].
    Nakata H; Kaneko K; Nakayama C; Kimoto T; Nakayama T
    Rinsho Hoshasen; 1984 Aug; 29(8):855-8. PubMed ID: 6096597
    [No Abstract]   [Full Text] [Related]  

  • 11. [Investigation of 99mTc-methylene diphosphonate scintigraphy of patients with lung cancer].
    Abe M; Ohde R; Ogata T; Kawaguchi S; Kikuchi K; Kawai T; Matsuzawa K; Takanoshi H
    Rinsho Hoshasen; 1982 Jun; 27(6):621-5. PubMed ID: 6292553
    [No Abstract]   [Full Text] [Related]  

  • 12. Hypercalcemia and bone metastases in breast cancer.
    Warrell RP
    Curr Opin Oncol; 1990 Dec; 2(6):1097-103. PubMed ID: 2151596
    [No Abstract]   [Full Text] [Related]  

  • 13. [Whole body bone scintigram with 99mTc-HMDP (technetium-99m-hydroxy methylene diphosphonate) (author's transl)].
    Isobe Y; Ko S; Umegaki Y; Takahashi S; Kawaguchi N; Wada S; Matsumoto S
    Radioisotopes; 1981 Nov; 30(11):606-8. PubMed ID: 7335900
    [No Abstract]   [Full Text] [Related]  

  • 14. Bisphosphonate effect on bone scintigraphy.
    Koizumi M; Ogata E
    J Nucl Med; 1996 Feb; 37(2):401. PubMed ID: 8667085
    [No Abstract]   [Full Text] [Related]  

  • 15. [Basic and clinical studies of 99mTc-hydroxymethylene diphosphonate for skeletal imaging agent].
    Ishine M; Kawamura M; Koizumi M; Itoh H; Murase K; Inatsuki S; Iio A; Hamamoto K
    Nihon Igaku Hoshasen Gakkai Zasshi; 1982 Apr; 42(4):389-97. PubMed ID: 6214765
    [No Abstract]   [Full Text] [Related]  

  • 16. [The occasional diagnosis of Plummer's disease during bone scintigraphy with 99mTc-HMDP].
    Saletnich I; Salvatori M; Summaria V; Giordano A
    Radiol Med; 1995 Apr; 89(4):551-4. PubMed ID: 7597246
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical studies on the detection of bone metastasis in lung cancer by bone scintigraphy].
    Nakano S; Hasegawa Y; Kajita A; Nakamura S; Horai T; Ikegami H; Matuda M; Okamoto N; Nabeshima H; Doi O; Komatubara Y; Ishigami S
    Kaku Igaku; 1983 Feb; 20(1):37-43. PubMed ID: 6308314
    [No Abstract]   [Full Text] [Related]  

  • 18. A parathyroid tumour demonstrated by bone scintigraphy.
    Feenstra H; Leytens J; Jöbsis AC; Van Royen EA
    Neth J Med; 1983; 26(3):88-90. PubMed ID: 6221197
    [No Abstract]   [Full Text] [Related]  

  • 19. Ewing's sarcoma seen as a "cold" lesion on bone scans.
    Bushnell D; Shirazi P; Khedkar N; Blank J
    Clin Nucl Med; 1983 Apr; 8(4):173-4. PubMed ID: 6851365
    [No Abstract]   [Full Text] [Related]  

  • 20. Technetium - 99M methylene-diphosphonate bone scan: mechanisms and clinical applications.
    Tan KF; Chang CH
    Singapore Med J; 1982 Apr; 23(2):61-72. PubMed ID: 6215712
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.